Bharat Immunologicals & Biologicals Corp. Ltd. announced earnings results for the second quarter ended September 30, 2019. For the second quarter, the company announced total revenue was INR 82.758 million compared to INR 47.758 million a year ago. Net loss was INR 56.591 million compared to INR 25.066 million a year ago. Basic loss per share was INR 1.28 compared to INR 0.58 a year ago. For the half year, total revenue was INR 171.203 million compared to INR 0 a year ago. Net loss was INR 116.258 million. Basic loss per share was INR 2.66.